Formulary coverage with utilization management — covered when listed subject to plan-specific requirements/limits
Formulary coverage is subject to plan-specific utilization management controls. Covered when listed, but only when all applicable requirements/limits are met:
The formulary table lists drugs and, in the Requirements/Limits column, any coverage controls applicable to that drug. Coverage for the listed drug is contingent on meeting those controls.
Common Requirements/Limits codes and meanings:
- PA (Prior Authorization): The plan or its designee requires prior approval before coverage will be provided. Examples in the formulary include many oncology agents (e.g., entries marked PA and/or OVM) and select specialty drugs.
- QL (Quantity Limit): The plan limits the quantity covered per designated time period (e.g., QL(31 EA per 31 days), QL(180 GM per 90 days), QL(3720 ML per 31 days)). The formulary specifies the exact limit for each product when applicable.
- ST (Step Therapy): The plan requires trial of specified medications before covering certain alternatives. See the formulary and the plan’s step therapy policy for details.
- OVM (Oncology Value Management): Prior authorization for antineoplastics and oncology supportive care drugs is required through the Oncology Value Management program (administered by OncoHealth); physicians must submit additional information to determine coverage.
- EX (Excluded): Drugs marked EX are not normally covered by the PDP; amounts paid for EX-coded drugs do not count toward total drug costs and, if applicable, do not count toward extra help qualification. Examples include some topical combination products and other specific items throughout the formulary.
- NDS (Non-Extended Day Supply): Certain controlled substances and other products are restricted to shorter maximum day supplies (e.g., many opioids and benzodiazepines limited to 30–31 day supplies).
The formulary contains many line-item examples showing these flags. For example:
- Oncology and targeted therapies (multiple entries) are commonly listed with PA; many are also flagged OVM (e.g., REVUFORJ = PA; OVM; VONJO = PA; OVM; ZOLINZA = PA; OVM).
- Quantity limits are specified for numerous products (e.g., celecoxib QL(180 EA per 90 days); diclofenac sodium external solution QL(600 ML per 30 days); ketorolac tablet QL(360 EA per 90 days); tramadol ER QL(31 EA per 31 days)).
- EX examples appear (e.g., HYDROCORTISONE/IODOQUINOL CREAM Requirements/Limits = EX; various combination topical products and select oral preparations are marked EX).
Coverage determinations will follow the Requirements/Limits shown; where PA, ST, QL, OVM or other controls are indicated, the plan may deny coverage if those requirements are not satisfied.
Members and prescribers should consult the formulary table for the specific product entry to determine the exact Requirements/Limits (including numeric quantity limits and program-specific notes such as generic equivalents or alternative listings). For full details on how to request prior authorization, step-therapy exceptions, or formulary exceptions, contact Customer Service or review the Evidence of Coverage and the plan’s prior authorization/step therapy documentation posted online.